Patent · US Active

Pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota

US10426765B2 · kind B2 · utility

0Cited by

2References

24Claims

0Family size

Assignee

CONARIS Research Institute AG · DE

Inventors

Georg Waetzig · Kiel, DE
Dirk Seegert · Dänischenhagen, DE

Key dates

Filing date	Jun 14, 2013
Grant date	Oct 1, 2019
Priority date	—
Expiry date	Jun 17, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a new pharmaceutical composition containing nicotinic acid, nicotinamide, tryptophanor related compounds for positively influencing the intestinal microbiota. In certain embodiments, the pharmaceutical composition is partially or entirely released into the small intestine or large intestine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.